[1]SIEGEL RL,MILLER KD,FUCHS HE,et al.Cancer statistics,2021[J].CA:A Cancer Journal for Clinicians,2021,71(1):7-33.
[2]HUANG MY,JIANG XM,WANG BL,et al.Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer:strategies and mechanisms[J].Pharmacol Ther,2021,219:107694.
[3]ZHU X,KUDO M,HUANG X,et al.Frontiers of microrna signature in non-small cell lung cancer[J].Front Cell Dev Biol,2021,9:643942.
[4]HWANG I,KIM JW,YLAYA K,et al.Tumor-associated macrophage,angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients[J].J Transl Med,2020,18(1):443.
[5]XU F,WEI Y,TANG Z,et al.Tumor associated macrophages in lung cancer:Friend or foe? (Review)[J].Mol Med Rep,2020,22(5):4107-4115.
[6]CASSETTA L,POLLARD JW.Tumor-associated macrophages[J].Curr Biol,2020,30(6):R246-R248.
[7]PATHRIA P,LOUIS TL,VARNER JA.Targeting tumor-associated macrophages in cancer[J].Trends Immunol,2019,40(4):310-327.
[8]MANTOVANI A,ALLAVENA P,SICA A,et al.Cancer-related inflammation[J].Nature,2008,454(7203):436-444.
[9]KALBASI A,KOMAR C,TOOKER GM,et al.Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma[J].Clin Cancer Res,2017,23(1):137-148.
[10]FRANKLIN RA,LIAO W,SARKAR A,et al.The cellular and molecular origin of tumor-associated macrophages[J].Science,2014,344(6186):921-925.
[11]CHANMEE T,ONTONG P,KONNO K,et al.Tumor-associated macrophages as major players in the tumor microenvironment[J].Cancers (Basel),2014,6(3):1670-1690.
[12]ZHANG SY,SONG XY,LI Y,et al.Tumor-associated macrophages:A promising target for a cancer immunotherapeutic strategy[J].Pharmacol Res,2020,161:105111.
[13]SAQIB U,SARKAR S.Phytochemicals as modulators of M1-M2 macrophages in inflammation[J].Oncotarget,2018,9(25):17937-17950.
[14]MURRAY PJ,ALLEN JE,BISWAS SK,et al.Macrophage activation and polarization:nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20.
[15]GRZYWA TM,SOSNOWSKA A,MATRYBA P,et al.Myeloid cell-derived arginase in cancer immune response[J].Frontiers in Immunology,2020,11:938.
[16]MITSI E,KAMNG'ONA R,RYLANCE J,et al.Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state[J].Respiratory Research,2018,19(1):1-4.
[17]WANG L,ZHANG S,WU H,et al.M2b macrophage polarization and its roles in diseases[J].Journal of Leukocyte Biology,2019,106(2):345-358.
[18]RAKAEE M,BUSUND LTR,JAMALY S,et al.Prognostic value of macrophage phenotypes in resectable non-small cell lung cancer assessed by multiplex immunohistochemistry[J].Neoplasia,2019,21(3):282-293.
[19]LIN Y,XU J,LAN H.Tumor-associated macrophages in tumor metastasis:biological roles and clinical therapeutic applications[J].Journal of Hematology & Oncology,2019,12(1):1-16.
[20]YIN M,LI X,TAN S,et al.Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer[J].The Journal of Clinical Investigation,2016,126(11):4157-4173.
[21]KNUTSDOTTIR H,CONDEELIS JS,PALSSON E.3-D individual cell based computational modeling of tumor cell-macrophage paracrine signaling mediated by EGF and CSF-1 gradients[J].Integrative Biology,2016,8(1):104-119.
[22]OSTUNI R,KRATOCHVILL F,MURRAY PJ,et al.Macrophages and cancer:from mechanisms to therapeutic implications[J].Trends in Immunology,2015,36(4):229-239.
[23]ZHANG J,LI H,WU Q,et al.Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth[J].Redox Biology,2019,22:101116.
[24]YIN M,LI X,TAN S,et al.Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer[J].The Journal of Clinical Investigation,2016,126(11):4157-4173.
[25]ZHANG S,CHE D,YANG F,et al.Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer[J].Oncotarget,2017,8(59):99801.
[26]GUO Z,SONG J,HAO J,et al.M2 macrophages promote NSCLC metastasis by upregulating CRYAB[J].Cell Death & Disease,2019,10(6):1-11.
[27]WANG A,LU C,NING Z,et al.Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation[J].Oncotarget,2017,8(17):28247.
[28]XIA Y,WEI Y,LI ZY,et al.Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages[J].Brain,Behavior,and Immunity,2019,81:111-121.
[29]HE C,ZHU K,BAI X,et al.Placental growth factor mediates crosstalk between lung cancer cells and tumor-associated macrophages in controlling cancer vascularization and growth[J].Cellular Physiology and Biochemistry,2018,47(6):2534-2543.
[30]KALE S,RAJA R,THORAT D,et al.Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin[J].Oncogene,2014,33(18):2295-2306.
[31]YANG Y,GUO Z,CHEN W,et al.M2 macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2[J].Molecular Therapy,2021,29(3):1226-1238.
[32]SOSA IGLESIAS V,GIURANNO L,DUBOIS LJ,et al.Drug resistance in non-small cell lung cancer:a potential for NOTCH targeting[J].Frontiers in Oncology,2018,8:267.
[33]YIN Y,YAO S,HU Y,et al.The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6[J].Clin Cancer Res,2017,23(23):7375-7387.
[34]LARIONOVA I,CHERDYNTSEVA N,LIU T,et al.Interaction of tumor-associated macrophages and cancer chemotherapy[J].Oncoimmunology,2019,8(7):e1596004.
[35]CHEN Y,SONG Y,DU W,et al.Tumor-associated macrophages:an accomplice in solid tumor progression[J].Journal of Biomedical Science,2019,26(1):1-13.
[36]RUFFELL B,COUSSENS LM.Macrophages and therapeutic resistance in cancer[J].Cancer Cell,2015,27(4):462-472.
[37]JAYASINGAM SD,CITARTAN M,THANG TH,et al.Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue:technicalities and challenges in routine clinical practice[J].Frontiers in Oncology,2020,9:1512.
[38]HUANG WC,KUO KT,WANG CH,et al.Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway[J].Journal of Experimental & Clinical Cancer Research,2019,38(1):1-17.
[39]ZHANG C,YU X,GAO L,et al.Noninvasive imaging of CD206-positive M2 macrophages as an early biomarker for post-chemotherapy tumor relapse and lymph node metastasis[J].Theranostics,2017,7(17):4276-4288.
[40]QIN J,ZHANG X,TAN B,et al.Blocking P2X7-mediated macrophage polarization overcomes treatment resistance in lung cancer[J].Cancer Immunology Research,2020,8(11):1426-1439.
[41]ZHU S,LUO Z,LI X,et al.Tumor-associated macrophages:Role in tumorigenesis and immunotherapy implications[J].Journal of Cancer,2021,12(1):54-64.
[42]ZHOU J,TANG Z,GAO S,et al.Tumor-associated macrophages:recent insights and therapies[J].Frontiers in Oncology,2020,10:188.
[43]PANG L,HAN S,JIAO Y,et al.Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation,migration,invasion and immunosuppression of non-small cell lung cancer,partially via IL-10 and PD-L1 regulation[J].International Journal of Oncology,2017,51(1):25-38.
[44]WABNITZ GH,H KIRCHGESSNER,JAHRAUS B,et al.PP1α and Cofilin regulate nuclear translocation of NF κB and promote expression of the anti-inflammatory cytokine IL-10 by T-cells[J].Mol Cell Biol,2018,38(22):e00041-18.
[45]GRZYWA TM,SOSNOWSKA A,MATRYBA P,et al.Myeloid cell-derived arginase in cancer immune response[J].Frontiers in Immunology,2020,11:938.